White paper: How to mitigate risk and create competitive advantage with a new model of pharmaceutical logistics

By Christopher Engel |

The rise of low volume and high value specialty drugs, complexities arising from large portfolios, global market reach, and patient customization all have a significant impact on supply chain efficiency.

Download our white paper and find out how to create competitive advantage by developing a fit-for-purpose supply chain that supports the market’s paradigm shift.


About the Author

A portrait of Christopher Engel.

Christopher Engel

Product Manager - Commercial Supply Chain NCEE
World Courier

Chris Engel has a strong background in logistics and has intercultural working experiences in China and Switzerland.

Since 2008 Chris held several sales responsibilities and roles in logistics, has been handling major worldwide accounts at TNT Express and FedEx, and also has experience in managing global pharmaceutical clients at World Courier as a Global Account Manager.

During his time in World Courier since 2014, Chris worked on and has lead numerous projects for high value specialty drugs and shipments of exceptional sensitivity, low tolerance to temperature deviations and challenging time requirements. He has been using his expertise to manage and design complex supply chains for both worldwide clinical trials and commercial drugs.

As a Product Manager for Commercial Supply Chain being responsible for Northern, Central and Eastern Europe in World Courier, Chris is helping clients with the transition from clinical to commercial drug logistics, including product launch, drugs with volatile demand and all volumes from single dosages to bulk shipments.

View Bio